Immediate Impact
14 standout
Citing Papers
A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy
2023 Standout
Antibody–Drug Conjugates: A Review of Approved Drugs and Their Clinical Level of Evidence
2023 Standout
Works of Sylvain Pilorge being referenced
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Sylvain Pilorge | 79 | 57 | 37 | 61 | 16 | 176 | |
| Colin Phipps Diong | 89 | 43 | 27 | 47 | 23 | 264 | |
| Béatrice Delmas-Marsalet | 83 | 41 | 37 | 62 | 15 | 190 | |
| Erin Coughlin | 83 | 130 | 23 | 51 | 15 | 273 | |
| Achille Aouba | 26 | 57 | 34 | 56 | 16 | 241 | |
| Francisco J. Márquez‐Malaver | 66 | 167 | 37 | 37 | 21 | 258 | |
| Joaquín Sánchez‐García | 76 | 163 | 65 | 51 | 25 | 292 | |
| Chiara Quadrelli | 86 | 40 | 21 | 22 | 13 | 169 | |
| Daniela Vallerini | 111 | 52 | 48 | 41 | 14 | 224 | |
| Stephanie Mathews | 92 | 29 | 44 | 85 | 17 | 200 | |
| Inna Timofeeva | 123 | 123 | 14 | 62 | 15 | 262 |
All Works
Loading papers...